Delivery Order SPE2DB24D3013-SPE2DB25FFQPX
Award Date 9/15/25
Potential Completion Date 9/16/25
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $7,904.97 to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (90-count packages). This firm fixed-price, non-set-aside contract was awarded on August 25, 2025, with an ultimate completion date of August 26, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Myrbetriq is a prescription medication used to treat overactive bladder, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $5,528.86 to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (90-count supply). This competitively awarded, firm fixed-price delivery order was issued on August 27, 2025, with an ultimate completion date of August 28, 2025. The contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Myrbetriq is a prescription medication used to treat...
- The Defense Logistics Agency awarded a $3,722.97 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Myrbetriq ER 50 mg, a medication used to treat overactive bladder. This non-set-aside, competitively awarded contract utilized firm fixed pricing and is scheduled for completion by August 25, 2025. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 22, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) with a ceiling value of $38,427.53. This firm fixed-price, non-set-aside contract is classified as a delivery order and represents a single transaction under a larger contract vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of April 23, 2025....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) with a ceiling value of $36,782.80. This firm fixed-price delivery order, which has an ultimate completion date of August 12, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was not set-aside and was competitively awarded, with...
- The Defense Logistics Agency awarded a $38,869.51 delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Myrbetriq ER 50 mg, a medication used to treat overactive bladder. This firm fixed-price, competitively awarded delivery order is scheduled for completion by July 28, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award carries no set-aside designation and represents a routine pharmaceutical procurement through the federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count) with a ceiling value of $5,024.66. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The contract requires completion by August 18, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Myrbetriq is a prescription medication...
- The Defense Logistics Agency awarded a delivery order valued at $6,157.53 to AmerisourceBergen Drug Corp for 90 tablets of Myrbetriq ER 50 mg, a medication used to treat overactive bladder. This competitively awarded, non-set-aside delivery order was issued on August 15, 2025, with an ultimate completion date of August 18, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with firm fixed pricing terms. This delivery order falls under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,109.65 to AmerisourceBergen Drug Corp for 90 tablets of Myrbetriq ER 50 mg, a medication used to treat overactive bladder. Awarded on August 11, 2025, with completion expected by August 12, 2025, this firm fixed-price delivery order carries no set-aside designation and represents a competitively awarded contract. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $4,013.94 to AmerisourceBergen Drug Corp for 90-count tablets of Myrbetriq ER 50 mg, a medication used to treat overactive bladder. Awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, this firm fixed-price contract utilized competitive procedures with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...